Loading Events

« All Events

  • This event has passed.

Heart UK Virtual Lipid Update 2020

November 24 2020

Heart UK are delighted to present this free of charge, CPD accredited event for healthcare professionals both in the UK and internationally.

The morning session will be chaired by Dr Dermot Neely who is currently Special Advisor on Lipids to the Academic Health Sciences Network for North East and North Cumbria, a member of the AAC Rapid Uptake Products Working Group on PCSK9 inhibitors and sits on the NHSE Specialist Advisory Group on Familial Hypercholesterolaemia. The afternoon session will be chaired by Dr Handrean Soran, Consultant Physician and Endocrinologist & Honorary Senior Lecturer at Manchester University Hospitals NHS Foundation Trust.

Topics to be covered at the event include:

  • Familial Hypercholesterolaemia
  • Familial Chylomicronaemia
  • Hyperlipidaemia and COVID-19
  • Screening and therapies

A full programme outline can be found on the Heart UK website as well as a link to register for the event.


United Kingdom


01628 777046
View Organiser Website
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.